The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans
- PMID: 19491838
- DOI: 10.1038/ajg.2009.238
The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans
Abstract
Objectives: Non-alcoholic fatty liver disease (NAFLD) is known to be related to factors that predict the development of coronary heart disease (CHD), such as dyslipidemia, central obesity, and metabolic syndrome (MS). The aim of this study was to determine whether individuals with NAFLD have an elevated risk of CHD, as estimated using the Framingham risk score (FRS).
Methods: A total of 21,130 individuals who underwent a voluntary general health examination were recruited. NAFLD was diagnosed among these individuals on the basis of typical sonographic findings and a level of alcohol consumption of <20 g/day. Of the 21,130 individuals, 3,780 were excluded because they had known causes of liver disease (1,690 were alcoholics, 975 had hepatitis B virus, 242 had hepatitis C virus, 91 had other hepatitis history, and 593 were taking medication known to produce fatty liver) or a history of heart disease (189).
Results: NAFLD was diagnosed in 5,769 of the 17,350 individuals (33.3%). The 11,581 normal individuals constituted the control group. The 5,769 individuals with NAFLD were split into two groups on the basis of ultrasonographic findings, that is, into a mild NAFLD group (n=3,278) and a moderate-severe NAFLD group (n=2,491). Individuals with NAFLD had an elevated risk of CHD, as estimated using FRS. Multivariable regression analysis, adjusted for confounding factors, showed a strong association between a higher FRS and NAFLD.
Conclusions: Individuals with ultrasonographically detected NAFLD have an elevated 10-year risk of developing CHD as estimated using FRS. Furthermore, NAFLD was found to be independently related to the risk of developing CHD, regardless of classical risk factors and other components of MS.
Similar articles
-
Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States.Hepatology. 2006 May;43(5):1145-51. doi: 10.1002/hep.21171. Hepatology. 2006. PMID: 16628637
-
High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease.Arch Med Res. 2009 Oct;40(7):571-5. doi: 10.1016/j.arcmed.2009.07.009. Epub 2009 Sep 25. Arch Med Res. 2009. PMID: 20082871
-
NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study.Am J Gastroenterol. 2009 Apr;104(4):861-7. doi: 10.1038/ajg.2009.67. Epub 2009 Mar 17. Am J Gastroenterol. 2009. PMID: 19293782
-
Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens.Diabet Med. 2007 Jan;24(1):1-6. doi: 10.1111/j.1464-5491.2007.02025.x. Diabet Med. 2007. PMID: 17227317 Review.
-
The role of non-alcoholic fatty liver disease in cardiovascular disease.Dig Dis. 2010;28(1):210-3. doi: 10.1159/000282088. Epub 2010 May 7. Dig Dis. 2010. PMID: 20460913 Review.
Cited by
-
The influence of metabolic factors for nonalcoholic Fatty liver disease in women.Biomed Res Int. 2015;2015:131528. doi: 10.1155/2015/131528. Epub 2015 Apr 20. Biomed Res Int. 2015. PMID: 25973422 Free PMC article.
-
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.World J Gastroenterol. 2017 Dec 21;23(47):8263-8276. doi: 10.3748/wjg.v23.i47.8263. World J Gastroenterol. 2017. PMID: 29307986 Free PMC article. Review.
-
Hard clinical outcomes in patients with NAFLD.Hepatol Int. 2013 Dec;7 Suppl 2:790-9. doi: 10.1007/s12072-013-9455-y. Epub 2013 Aug 6. Hepatol Int. 2013. PMID: 26202293
-
KASL clinical practice guidelines: management of nonalcoholic fatty liver disease.Clin Mol Hepatol. 2013 Dec;19(4):325-48. doi: 10.3350/cmh.2013.19.4.325. Epub 2013 Dec 28. Clin Mol Hepatol. 2013. PMID: 24459637 Free PMC article. Review. No abstract available.
-
Elevated Alanine Aminotransferase in Early Pregnancy and Subsequent Development of Gestational Diabetes and Preeclampsia.J Korean Med Sci. 2020 Jul 6;35(26):e198. doi: 10.3346/jkms.2020.35.e198. J Korean Med Sci. 2020. PMID: 32627436 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical